An interventional study of Stress Ball in Gastrointestinal System Cancer, sponsored by Artvin Coruh University. Recruiting at 1 site in Turkey (Türkiye). Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-02-11.
Sponsored by Artvin Coruh University · Not applicable, Interventional, and Supportive care
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 21 studies in Gastrointestinal Neoplasms with a site in Turkey — 3 open to participants now, 5 under way, 1 of them phase 3. Gastrointestinal Neoplasms · Turkey.
Among the 21 studies in Gastrointestinal Neoplasms with a site in Turkey, this one is one of 3 that started in 2026, is one of 4 with no phase, and was the 18th registered.
698 studies on the registry are indexed under Gastrointestinal Neoplasms; 211 are open to participants now.
Browse Gastrointestinal Neoplasms studies →3 of the 21 studies in Gastrointestinal Neoplasms with a site in Turkey are open now. Recruiting first, the newest first:
Van Training and Research Hospital · Sites in Turkey
Ages 60+
Van Training and Research Hospital · Sites in Turkey
Ages 60+
A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →
Of the 160 Gastrointestinal Neoplasms studies recruiting now, 121 (76%) set no upper age limit and 19 (12%) stop at 75 or younger; 8 take children under 18; 10 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
21 studies; the count open now beside each. This study's row is marked.
First in 2004; this study’s year is marked. 3 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 60 is below the median of 73 across 497 interventional studies indexed under Gastrointestinal Neoplasms.
Median enrollment 140 across the 7 interventional studies, 100 across the 13 observational. Of the 14 that completed or were terminated, 1 (7%) have results posted.
This tab as a report to print or save as PDF → With an account.
4 of 21 have an industry lead sponsor. The 10 most frequent:
Artvin Coruh University is the lead sponsor of 31 studies on the registry; 18 are open to participants now.
Artvin Coruh University has 1 study filed under Gastrointestinal Neoplasms — fewer than ten, so there is no comparison to draw.
3 of the studies in Gastrointestinal Neoplasms with a site in Turkey that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07383935Artvin Coruh UniversityStress Ball Use During Chemotherapy in Gastrointestinal Cancer Patients | 2027-02-03 |
| NCT07815392Van Training and Research HospitalPreoperative Frailty and Postoperative Outcomes in Older Patients Undergoing Surgery for Gastrointestinal Cancer | 2027-06-01 |
| NCT07817758Van Training and Research HospitalPreoperative Sarcopenia and Postoperative Outcomes in Older Patients With Gastrointestinal Cancer | 2027-06-01 |
Add all 3 to your calendar (.ics) → With an account.
Among the 21 studies in Gastrointestinal Neoplasms with a site in Turkey, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This study will investigate whether using a stress ball during chemotherapy can reduce anxiety, fear, and changes in vital signs in patients with gastrointestinal system cancers.
Patients receiving chemotherapy for gastrointestinal cancers often experience anxiety and fear, which may affect their heart rate, blood pressure, and breathing. A stress ball is a simple, low-cost, and safe method that may help patients relax during treatment.
In this randomized controlled study, 60 patients receiving chemotherapy will be assigned to either a stress ball group or a routine care group. Patients in the stress ball group will squeeze a stress ball for 15 minutes during their chemotherapy session. Anxiety, fear levels, and vital signs will be measured before and after chemotherapy in both groups.
The results of this study may help determine whether stress ball use is an effective non-drug method to improve emotional well-being and physiological stability in patients undergoing chemotherapy.
This study is a randomized controlled experimental trial designed to evaluate the effects of stress ball use during chemotherapy on anxiety, fear, and vital signs in patients with gastrointestinal system cancers.
Participants will be adult patients diagnosed with gastrointestinal system cancers who are receiving chemotherapy at the Artvin State Hospital Chemotherapy Unit. Eligible patients who provide informed consent will be randomly assigned in a 1:1 ratio to either an experimental group (stress ball intervention) or a control group (routine care).
Patients in the experimental group will be instructed to squeeze a medium-firm stress ball for 15 minutes starting at the beginning of their chemotherapy session. They will be guided to inhale while squeezing the ball and exhale while releasing it, focusing their attention on the activity. Patients in the control group will receive routine chemotherapy care without any additional intervention.
Anxiety and fear levels will be assessed before and after chemotherapy using validated measurement tools. Vital signs including blood pressure, heart rate, respiratory rate, body temperature, and oxygen saturation will also be recorded before and after the chemotherapy session. Outcomes will be compared between and within groups to determine the effectiveness of the stress ball intervention.
This study aims to provide evidence on whether a simple non-pharmacological method can improve psychological well-being and physiological stability during chemotherapy in patients with gastrointestinal system cancers.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
-
Participants in this arm will receive routine chemotherapy care and will additionally perform stress ball squeezing for 15 minutes starting at the beginning of the chemotherapy session. Patients will be instructed to inhale while squeezing the ball and exhale while releasing it, focusing attention on the activity.
Behavioral: Stress Ball
Participants in this arm will receive routine chemotherapy care during their chemotherapy session and will not perform any stress ball or additional relaxation intervention.
The intervention consists of guided stress ball squeezing during chemotherapy. A round, medium-firm, compressible stress ball approximately 5-6 cm in diameter will be provided to participants. Starting at the beginning of the chemotherapy session, participants will squeeze the stress ball continuously for 15 minutes. They will be instructed to inhale while squeezing the ball, exhale while releasing their grip, and focus their attention on the squeezing activity. Disposable gloves will be used to maintain hygiene during the intervention. No additional behavioral or pharmacological interventions will be applied.
State Anxiety (STAI-State) score
Time frame: Baseline (before chemotherapy session) and immediately after chemotherapy session
Fear Severity (VAS-Fear)
Fear severity will be measured using a Visual Analog Scale (VAS-Fear). The change in scores before and after chemotherapy will be evaluated to assess the effect of the intervention on fear.
Time frame: Baseline (before chemotherapy session) and immediately after chemotherapy session
Systolic Blood Pressure
Systolic blood pressure measured using an automatic sphygmomanometer.
Time frame: Baseline (immediately before chemotherapy session) and immediately after completion of the chemotherapy session.
Diastolic Blood Pressure
Diastolic blood pressure measured using an automatic sphygmomanometer.
Time frame: Baseline (immediately before chemotherapy session) and immediately after completion of the chemotherapy session.
Heart Rate (Pulse)
Heart rate measured in beats per minute using an pulse oximeter
Time frame: Baseline (immediately before chemotherapy session) and immediately after completion of the chemotherapy session.
Respiratory Rate
Respiratory rate measured by counting chest movements for one minute.
Time frame: Baseline (immediately before chemotherapy session) and immediately after completion of the chemotherapy session
Body Temperature
Body temperature measured using a tympanic thermometer.
Time frame: Baseline (immediately before chemotherapy session) and immediately after completion of the chemotherapy session.
Oxygen Saturation (SpO₂)
Time frame: Baseline (immediately before chemotherapy session) and immediately after completion of the chemotherapy session.
Plan to share: Undecided
No publications or documents are linked to this record.
Started Feb 2026 (actual). Primary completion is estimated for Feb 2027, 12 months after the start.
Of 154 non-industry interventional studies with no phase under Gastrointestinal Neoplasms, half reached primary completion within 39 months of starting (the median), counting those still running; a quarter within 19 and three quarters within 71. This study's planned 12 months is below that.
Counting every sponsor, half of 164 studies reached it within 36 months; a quarter within 17 and three quarters within 71.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Artvin Coruh University